Skip to main content
. Author manuscript; available in PMC: 2017 Jun 15.
Published in final edited form as: Cancer. 2016 Mar 15;122(12):1913–1920. doi: 10.1002/cncr.29972

Table 3.

Anticipation effect in families with BRCA1/2 mutations after controlling for ascertainment bias

Breast Cancer, probands excluded
(N=447)
Ovarian Cancer, probands excluded (N=67)
Generation N Mean
AoO
Δ AoO (95% CI) P-value N Mean
AoO
Δ AoO (95% CI) P-value
Grandparents’ gen 81 51.5 10.5 (6.6, 14.3) <0.001 14 56.9 8.6 (1.7, 15.5) 0.014
Parents’ gen 189 48.0 7.0 (4.2, 9.7) <0.001 32 52.7 4.4 (−1.0, 9.8) 0.11
Probands’ gen 146 41.0 0 (ref) 19 48.3 0 (ref)
Children’s gen 31 35.0 −6.0 (−10.7, 1.3) 0.013 2 37.9 −10.4 (−24.2, 3.3) 0.14

mutation probability-weighted age of onset in years

Abbreviations: Δ AoO, difference in years of age of onset; CI, confidence intervals; gen, generation; ref, reference.